Breaking News Headlines Today

News from Cardiac Interventions Today

See all of Cardiac Interventions Today news coverage in one place. Discover how Cardiac Interventions Today’s media bias informs their coverage and compare with thousands of other news outlets.

In total, 28 have been published by Cardiac Interventions Today which Ground News has aggregated in the past 3 months.

The Ground News media bias check for Cardiac Interventions Today is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

Cardiac Interventions Today’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Cardiac Interventions Today

Where is Cardiac Interventions Today located?Cardiac Interventions Today's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Cardiac Interventions Today News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding Its Coronary Clinical Program Across the U.S. and Europe

67% Center coverage: 3 sources

TAMPA, Fla.--(BUSINESS WIRE)--Aug 4, 2025-See the Story

Atlanta, Georgia · Atlanta

Image-guided crossing and re-entry system used for first time in coronary CTO trial - Cardiovascular News

Simpson Interventions has announced that its Acolyte image-guided crossing and re-entry catheter system has been successfully used to treat the first patients in the Acolyte study, a pivotal investigational device exemption IDE clinical trial designed to assess the safety and effectiveness of the system in treating coronary chronic total occlusions (CTOs) with persistent symptoms following medical therapy. “Our team is thrilled to have successfu…See the Story

United States · United States

Gentuity and GE HealthCare Collaborate to Improve Availability of Imaging Systems - Cardiovascular News

Gentuity has announced an agreement with GE HealthCare to collaborate on commercial activities. The collaboration is intended to enhance the availability, adoption, and functionality of highly complementary imaging solutions for interventional cardiology, the companies have announced in a press release. As part of the agreement, Gentuity and GE HealthCare aim to jointly pursue co-marketing initiatives and technical integration of their respectiv…See the Story

FDA Issues Early Alert on Boston Scientific’s Watchman Access System - Cardiac Interventions Today

August 11, 2025—The FDA recently advised that Boston Scientific has issued a letter to affected customers recommending all lots of certain Watchman access systems have updated instructions for use (IFU). The devices are intended to provide vascular and transseptal access for Boston Scientific’s family of Watchman FLX left atrial appendage closure devices with delivery systems. The reason for the action is that Boston Scientific has identified a …Boston, Massachusetts · Boston Read Article

Boston Scientific’s Agent DCB Granted NTAP From CMS - Cardiac Interventions Today

August 4, 2025—Boston Scientific recently announced that the US Centers for Medicare & Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for the company’s Agent drug-coated balloon (DCB). Beginning October 1, 2025, CMS will provide hospitals with additional device reimbursement when the Agent DCB is used for eligible cases in the hospital inpatient setting, advised the company. The Agent DCB received FDA approval in the Unit…United States · United States Read Article

Impulse Dynamics® Completes Enrollment of Pivotal Trial for CCM-D® HF System and Earns Category 1 CPT Codes for CCM® Therapy

100% Left coverage: 6 sources

MARLTON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced two major accomplishments, marking an inflection point in the advancement and accessibility of…New Jersey · New Jersey See the Story

XyloCor Begins EXACT-2 Trial of Catheter-Based XC001 Gene Therapy to Treat of CAD - Cardiac Interventions Today

July 25, 2025—XyloCor Therapeutics, a biopharmaceutical company developing therapies for cardiovascular disease, recently announced the first patient has been enrolled in the EXACT-2 trial. The phase 2b, multicenter, randomized, double-blind study is evaluating the company’s catheter-based gene therapy candidate XC001 (encoberminogene rezmadenovec) in patients with coronary artery disease and refractory angina. EXACT-2, which is composed of 100 …Maryland · Maryland Read Article

Results of DECIDE registry presented at SCCT 2025 - Cardiovascular News

Heartflow has announced new data for its artificial intelligence (AI)-enabled Heartflow Plaque Analysis, including final primary endpoint data from the DECIDE registry. Data from the DECIDE registry showed Heartflow Plaque Analysis led to medical management change in over half of patients beyond coronary computed tomography angiography (CCTA) alone, regardless of traditional risk factors or CCTA findings. The DECIDE registry is the largest prosp…Artificial Intelligence · Montreal See the Story

Biosensors Imperia Delivery System Receives CE Mark Approval - Cardiac Interventions Today

July 17, 2025—Biosensors International recently announced it received CE Mark certification for the Imperia delivery system under the European Union Medical Device Regulation 2017/745. The Imperia device is now commercially available across Europe. According to the company, the Imperia device is part of the Biosensors Allegra self-expanding, supra-annular, transcatheter heart valve (THV). Allegra is intended for transfemoral implantation of the …Maryland · Maryland Read Article

Familiar Anti-Inflammatory Felled by Strokes in TAVR Trial

100% Center coverage: 1 sources

(MedPage Today) -- The inflammation suppressant colchicine could show more promise in transcatheter aortic valve replacement (TAVR) -- if not for excess strokes, as seen in one small randomized study. In the Co-STAR double-blind trial, periprocedural...See the Story

First Subject Enrolled in Trial of Medtronic’s Liquid Embolic System

Medtronic has announced the first subject enrolment in the PELE trial, aiming to assess the Onyx liquid embolic system (LES).The post First subject enrolled in trial of Medtronic’s liquid embolic system appeared first on Medical Device Network.Albany, New York · Albany See the Story

News from Cardiac Interventions Today

News from Cardiac Interventions Today

Information about Cardiac Interventions Today

Media Bias Ratings

Factuality

Ownership

Top Cardiac Interventions Today News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding Its Coronary Clinical Program Across the U.S. and Europe

Image-guided crossing and re-entry system used for first time in coronary CTO trial - Cardiovascular News

Gentuity and GE HealthCare Collaborate to Improve Availability of Imaging Systems - Cardiovascular News

FDA Issues Early Alert on Boston Scientific’s Watchman Access System - Cardiac Interventions Today

Boston Scientific’s Agent DCB Granted NTAP From CMS - Cardiac Interventions Today

Impulse Dynamics® Completes Enrollment of Pivotal Trial for CCM-D® HF System and Earns Category 1 CPT Codes for CCM® Therapy

XyloCor Begins EXACT-2 Trial of Catheter-Based XC001 Gene Therapy to Treat of CAD - Cardiac Interventions Today

Results of DECIDE registry presented at SCCT 2025 - Cardiovascular News

Biosensors Imperia Delivery System Receives CE Mark Approval - Cardiac Interventions Today

Familiar Anti-Inflammatory Felled by Strokes in TAVR Trial

First Subject Enrolled in Trial of Medtronic’s Liquid Embolic System

Similar News Topics

Topics Most Covered by Cardiac Interventions Today

Sources Covering Similar Topics

Breaking News Topics Related to Cardiac Interventions Today

Information about Cardiac Interventions Today

Media Bias Ratings

Factuality

Ownership

FDA Issues Early Alert on Boston Scientific’s Watchman Access System - Cardiac Interventions Today

Boston Scientific’s Agent DCB Granted NTAP From CMS - Cardiac Interventions Today

Impulse Dynamics® Completes Enrollment of Pivotal Trial for CCM-D® HF System and Earns Category 1 CPT Codes for CCM® Therapy

XyloCor Begins EXACT-2 Trial of Catheter-Based XC001 Gene Therapy to Treat of CAD - Cardiac Interventions Today

Results of DECIDE registry presented at SCCT 2025 - Cardiovascular News

Biosensors Imperia Delivery System Receives CE Mark Approval - Cardiac Interventions Today

Familiar Anti-Inflammatory Felled by Strokes in TAVR Trial

First Subject Enrolled in Trial of Medtronic’s Liquid Embolic System